trending Market Intelligence /marketintelligence/en/news-insights/trending/epdpCfJudtlEkpWBY_SIrg2 content esgSubNav
In This List

Kubota Pharmaceutical to form ophthalmology joint venture with SBI Holdings

Case Study

Identifying PPE Suppliers During the Pandemic

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective


Kubota Pharmaceutical to form ophthalmology joint venture with SBI Holdings

Kubota Pharmaceutical Holdings Co. Ltd. plans to form a joint venture with SBI Holdings Inc. to invest in ophthalmic drugs and devices.

The entity will be 51% funded by Kubota Pharma and 49% by SBI Holdings and is likely to first invest in mobile healthcare applications in the field of ophthalmology.

Kubota Pharmaceutical is the parent of Acucela Inc.